Anteilseigner
Fidelity Management & Research Co. LLC (12,55 %) Paradigm BioCapital Advisors LP (8,02 %) SSgA Funds Management, Inc. (7,15 %) Venrock Associates (6,19 %) Perceptive Advisors LLC (5,83 %) BlackRock Fund Advisors (5,51 %) Deep Track Capital LP (5,51 %) The Vanguard Group, Inc. (4,97 %) Maverick Capital Ltd. (4,29 %) Commodore Capital LP (3,08 %) Fairmount Funds Management LLC (2,94 %) AllianceBernstein LP (2,74 %) Vivo Capital LLC (2,67 %) Great Point Partners LLC (2,13 %) Geode Capital Management LLC (1,85 %) Novo Holdings A/ S (Investment Company) (1,75 %) Pictet Asset Management SA (1,75 %) Yiheng Capital Management LP (1,51 %) Polar Capital LLP (1,42 %)
Kontakt
Viridian Therapeutics Inc.